Gary Ferguson, MD
Enriched profileDirector, Pulmonary Research Institute of Southeast Michigan · Pulmonary Research Institute of Southeast Michigan
Gary Ferguson is Director, Pulmonary Research Institute of Southeast Michigan at Pulmonary Research Institute of Southeast Michigan. OpenAlex indexes 285 publications with 16,961 citations (h-index 50); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Gary T. Ferguson, MD, is Director, Pulmonary Research Institute of Southeast Michigan. The public record shows 285 publications with 16,961 citations (h-index 50), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 8 companies.
- Most recent indexed publication: 2025 · International journal of chronic obstructive pulmonary disease
- Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 112.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- ProAir Digihaler in COPD Disease Management: A Real World Study
Sponsor: Pulmonary Research Institute of Southeast Michigan
- Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD
Sponsor: Pulmonary Research Institute of Southeast Michigan
- Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Industry payments
Updated 15 Oct 2026
8 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202315 payments$10,224openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20236 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Short-acting sulfonamides100%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Albuterol Digihaler in COPD Disease Management: A Real-World Study to Assess Digihaler Inhalation Parameters, Thresholds and Their Use to Identify Deterioration in Clinical Practice.
International journal of chronic obstructive pulmonary disease
Clinical Trial2025 - Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies.
NPJ primary care respiratory medicine
Clinical Trial2020
Most-cited works
by citation count (OpenAlex)Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
reachmd.com/profiles/gary-ferguson-md-fccp/LA4ql9/biography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Washington School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Board Certified
Pulmonary Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Board Certified
Critical Care Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Fellow
American College of Chest Physicians (F.C.C.P.)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Editorial & leadership roles
journal and society appointments- Editorial board member
Journal COPD (COPD: Journal of Chronic Obstructive Pulmonary Disease)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor of Medicine
Michigan State University (College of Human Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Director of Pulmonary Research
Providence/St. John Health System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗ - Scientific Advisory Board Member
Altesa BioSciences, Inc.
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →altesabio.com ↗ - Scientific Advisor
DevPro Biopharma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →devprobiopharma.com ↗ - Affiliated physician
Corewell Health Farmington Hills Hospital and Ascension Providence Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →md.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital